Cargando…
Designing Safer CRISPR/Cas9 Therapeutics for HIV: Defining Factors That Regulate and Technologies Used to Detect Off-Target Editing
Human immunodeficiency virus type-1 (HIV-1) infection has resulted in the death of upward of 39 million people since being discovered in the early 1980s. A cure strategy for HIV-1 has eluded scientists, but gene editing technologies such as clustered regularly interspaced short palindromic repeats (...
Autores principales: | Sullivan, Neil T., Allen, Alexander G., Atkins, Andrew J., Chung, Cheng-Han, Dampier, Will, Nonnemacher, Michael R., Wigdahl, Brian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434968/ https://www.ncbi.nlm.nih.gov/pubmed/32903440 http://dx.doi.org/10.3389/fmicb.2020.01872 |
Ejemplares similares
-
Off-Target Analysis in Gene Editing and Applications for Clinical Translation of CRISPR/Cas9 in HIV-1 Therapy
por: Atkins, Andrew, et al.
Publicado: (2021) -
Gene Editing of HIV-1 Co-receptors to Prevent and/or Cure Virus Infection
por: Allen, Alexander G., et al.
Publicado: (2018) -
Safe CRISPR-Cas9 Inhibition of HIV-1 with High Specificity and Broad-Spectrum Activity by Targeting LTR NF-κB Binding Sites
por: Chung, Cheng-Han, et al.
Publicado: (2020) -
Computational Design of gRNAs Targeting Genetic Variants Across HIV-1 Subtypes for CRISPR-Mediated Antiviral Therapy
por: Chung, Cheng-Han, et al.
Publicado: (2021) -
Assessment of anti-HIV-1 guide RNA efficacy in cells containing the viral target sequence, corresponding gRNA, and CRISPR/Cas9
por: Allen, Alexander G., et al.
Publicado: (2023)